Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.485 USD | -2.92% | -12.12% | -28.98% |
Evolution of the average Target Price on Adaptive Biotechnologies Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Adaptive Biotechnologies Corporation
JPMorgan Chase | |
Morgan Stanley | |
BofA Securities | |
Scotiabank | |
Piper Sandler | |
Credit Suisse | |
BTIG | |
Goldman Sachs |
EPS Revisions
- Stock Market
- Equities
- ADPT Stock
- Consensus Adaptive Biotechnologies Corporation